Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
透過分析師的洞察，揭示ADMA生物製劑的底層原理
6 analysts have shared their evaluations of ADMA Biologics (NASDAQ:ADMA) during the recent three months, expressing a mix of bullish and bearish perspectives.
在最近三個月中，有6位分析師分享了他們對ADMA Biologics（納斯達克：ADMA）的評估，表達了看好和看淡的觀點。
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
下表提供了他們最近的評級概況，突出了過去30天內情緒的變化，並將其與之前的月份進行了比較。
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $10.58, along with a high estimate of $14.00 and a low estimate of $7.50. This upward trend is evident, with the current average reflecting a 23.31% increase from the previous average price target of $8.58.
在提供更深入的見解方面，分析師們已經制定了12個月的目標價位，表示平均目標價格爲10.58美元，最高估價爲14.00美元，最低估價爲7.50美元。這種上升趨勢很明顯，當前的平均價格比先前的平均目標價格8.58美元上漲了23.31%。
Investigating Analyst Ratings: An Elaborate Study
分析師評級的調查：一項詳盡的研究
The...
最...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。